|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1999-7-7
|
|
pubmed:abstractText |
A role for altered programmed cell death in cancer stems from the description of alterations on tumour-associated genes involved in the regulation of apoptosis such as p53 and bcl-2. The balance between the latter may have significant implications for the pathobiology of breast cancer. This study was therefore undertaken to evaluate the expression of these two gene products with opposite functions.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0309-0167
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
34
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
310-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10231398-Adult,
pubmed-meshheading:10231398-Aged,
pubmed-meshheading:10231398-Aged, 80 and over,
pubmed-meshheading:10231398-Breast Neoplasms,
pubmed-meshheading:10231398-Carcinoma, Ductal, Breast,
pubmed-meshheading:10231398-Carcinoma, Lobular,
pubmed-meshheading:10231398-Carcinoma in Situ,
pubmed-meshheading:10231398-Female,
pubmed-meshheading:10231398-Humans,
pubmed-meshheading:10231398-Immunohistochemistry,
pubmed-meshheading:10231398-Middle Aged,
pubmed-meshheading:10231398-Phenotype,
pubmed-meshheading:10231398-Predictive Value of Tests,
pubmed-meshheading:10231398-Prognosis,
pubmed-meshheading:10231398-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:10231398-Tumor Suppressor Protein p53
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
bcl-2 protein expression is associated with a prognostically favourable phenotype in breast cancer irrespective of p53 immunostaining.
|
|
pubmed:affiliation |
Department of Pathology, Medical Faculty of Athens University, Athens, Greece.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
